Narayana Hrudayalaya Ltd - 539551 - Meeting With Analyst/ Institutional Investor
Intimation of meeting with Analyst/ institutional investor02-06-2023
02-06-2023
Narayana Hrudayalaya extends gains, surges to a new 52-week high
Sentiment for Narayana Hrudayalaya has been running high since the release of its robust fourth quarter numbers on May 19, with net profit surging threefold on-year to Rs 173.2 crore01-06-2023
Narayana Hrudayalaya Ltd - 539551 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of Earnings Call for the quarter and year ended 31st March 2023.29-05-2023
Narayana Hrudayalaya Ltd - 539551 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Enclosed herewith Annual Secretarial Compliance Report for the Financial Year ended 31st March 2023.25-05-2023
Buy Narayana Hrudayalaya; target of Rs 980: Prabhudas Lilladher
Prabhudas Lilladher is bullish on Narayana Hrudayalaya has recommended buy rating on the stock with a target price of Rs 980 in its research report dated May 22, 2023.24-05-2023
Narayana Hrudayalaya Ltd - 539551 - Intimation Of Incorporation Of A Wholly Owned Subsidiary (WOS)
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (SEBI Listing Regulations) we hereby inform that the Company has incorporated a Wholly Owned Subsidiary named 'NARAYANA HEALTH INSURANCE LIMITED' on 24th May, 2023. The details as required under Regulation 30 of the Listing Regulations read with SEBI circular No. CIR/CFD/CMD/4/2015 dated 9th September 2015 are enclosed as Annexure.24-05-2023
Narayana Hrudayalaya Ltd - 539551 - Audio Recording Of Earning Call For The Quarter And Year Ended 31St March 2023
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), please be informed that the Earnings Call of the Company for the quarter and year ended 31st March,2023 was held on 22nd May 2023 and the Audio Recording w.r.t. the Earnings Call has been uploaded and is available on the website of the Company.23-05-2023
Narayana Hrudayalaya Ltd - 539551 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed herewith the copy of the newspaper advertisement published on Sunday, 21st May 2023 in English newspaper - Financial Express and Regional (Kannada) newspaper- Vijayavani.22-05-2023
Q4FY23 Quarterly & FY23 Annual Result Announced for Narayana Hrudayalaya Ltd.
Healthcare facilities company Narayana Hrudayalaya announced Q4FY23 & FY23 results: Consolidated Q4FY23: Total operating income was Rs 12,216 million for Q4FY23 as compared to Rs 9,407 million in Q4FY22, reflecting an increase of 29.9 % YoY and 8.3% QoQ EBITDA stood at Rs 2,904 million, reflecting a margin of 23.8 % as against Rs 1,848 million in Q4FY22, translating into YoY growth of 57.1 % and QoQ of 9.2% respectively Consolidated PAT stood at Rs 1,732 million, reflecting a margin of 23.8 % as compared to Rs 690 million in Q4FY22, translating into YoY growth of 151.2 % and QoQ degrowth of 12.6% respectively India operating income was Rs 9,771 million for Q4FY23 as compared to Rs 7,572 million in Q4FY22, reflecting an increase of 29.0% YoY and 8.9% QoQ HCCI operating income was Rs 2,445 million for Q4FY23 as compared to Rs 1,835 million in Q4FY22, reflecting an increase of 33.3% YoY and 5.9% QoQ Consolidated FY23: Total operating income was Rs 45,248 million for FY23 as compared to Rs 37,013 million in FY22 EBITDA of Rs 10,313 million for FY23, reflecting a margin of 22.8% as against Rs 6,881 million in FY22 PAT stood at Rs 6,066 million for FY23, reflecting a margin of 13.4% as compared to Rs 3,421 million in FY22 India operating income was Rs 36,424 million for FY23 as compared to Rs 30,120 million in FY22, reflecting an increase of 20.9% YoY HCCI operating income was Rs 8,824 million for FY23 as compared to Rs 6,893 million in FY22, reflecting an increase of 28.0% YoY Commenting on the performance, Emmanuel Rupert, Managing Director and Group CEO, Narayana Hrudayalaya, said “The current fiscal year exhibited robust financial performance. We are pleased to report the highest-ever revenue and profitability in the fourth quarter, as well as for the financial year, which is attributed to increased patient footfalls along with improvements in specialty and payor mix. The performance improvement is supported by the growth in business across our flagship units, other hospitals, and newer hospitals, in addition to the increased contribution of international patients. Our Cayman business demonstrated continued growth and contributed to the overall performance. We are in the phase of transforming our business to offer comprehensive healthcare services by becoming more patient-oriented digitally native and operationally efficient to offer quality integrated services at an affordable cost. While continuing to consolidate our operations, we would pursue growth opportunities both in India and overseas to derive synergies from our robust existing operations and maximize value for all our stakeholders." Result PDF22-05-2023
Narayana Hrudayalaya rallies 11% to hit a record high on strong Q4 results
The company reported the highest-ever revenue and profitability in Q4FY23, as well as for FY23, which is attributed to increased patient footfalls along with improvements in speciality and payor mix22-05-2023